Francesca Cottini retweeted
I spy a @FrancescaCottin 4th from the right 👀🎉 Congrats to all the awardees, especially her! 🌟👏
#CareerDevelopment #InnovationInResearch
Francesca Cottini retweeted
We're honored to announce that Francesca Cottini, MD, has earned the inaugural Mason Fisher Grant. The award, funded by @Pelotonia, supports research of genetic mutations that can lead to cancer. cancer.osu.edu/blog/hematolo…
Francesca Cottini retweeted
🥼 Researchers led by Dr. @FrancescaCottin at @OhioStateMed identified non-classical major histocompatibility complex class I molecule HLA-E as a major contributing factor in #immune escape.
👓 Learn more at @LeukemiaJnl | go.nature.com/3RKzdIG
Francesca Cottini retweeted
#Myeloma Paper of the Day: CREB1 promotes expression of immune checkpoint HLA-E, which binds to natural killer group 2A (NKG2A) inhibitory NK signal signal, leading to immune escape in multiple myeloma: pubmed.ncbi.nlm.nih.gov/3890….
Francesca Cottini retweeted
Myeloma Paper of the Day, June 24th, suggested by @Myeloma_Doc
@FrancescaCottin
oncodaily.com/91214.html
#Cancer #Myeloma #MyelomaPaperOfTheDay #OncoDaily #Oncology
Francesca Cottini retweeted
Excited to share our paper !
Hopefully the use of CAR T products expands in the future i
Promises and challenges of a decentralized CAR T-cell manufacturing model frontiersin.org/articles/10.…
@DrMarcosdelima @E_D_Bezerra @OSUHematology @OhioStateMedOnc
@HemOncFellows – at Columbus, OH
Francesca Cottini retweeted
Excite and honored to be a part of AMPATH myeloma workshop in Eldoret, Kenya, to educate and mentor providers, engage with key stakeholders and advocacy groups to make bispecific antibodies available in Western Africa. #AMPATH #MoiUniversity #IUCancerCenter #IUSchoolMedicine
Francesca Cottini retweeted
Pub Alert 🚨 Francesca Cottini, MD (@FrancescaCottin)
published "CD56 expression predicts response to Daratumumab-based regimens" in @BloodCancerJnl.
nature.com/articles/s41408-0…
#myeloma Happy to share the last work of our lab on the role of CD56 in predicting response to Dara-IMiDs in patients with myeloma. Thanks to my team, especially AJ Robinette @OSUHematology @OhioStateWIMS @Pelotonia
4
202
Francesca Cottini retweeted
Excellent @OSUCCC_James Oncogeriatric Grand Rounds today by @MegVoda 10% of skeleton bone is remodeled annually. Fascinated by 🦴 pits and trenches and relationship to #gerionc and senescence. @OSUHematology
Francesca Cottini retweeted
OncData had the pleasure of speaking with Dr. Evandro Bezerra (@E_D_Bezerra) of @OSUHematology about his study "Real-World Outcomes of #BrexuCel for R/R B-Cell #ALL. Stay tuned to hear the podcast!
Francesca Cottini retweeted
More photos from our Big Ten CRC lymphoid, myeloid, BMT/SCT, and multiple myeloma #ASH2023 meetings today! @CraigEmmittCole @strouse_chris @mpianko @nsc_natalie @LymphomaMD @FrancescaCottin @TMSchmidtMD @suvannasankha @DrAEvens
Francesca Cottini retweeted
Who says @OhioState and @UMich can’t get along? Thanks for the teamwork, Dr. Ryan Wilcox and @LymphomaMD John Reneau! @OSUCCC_James @UMRogelCancer #ASH2023
Scientific workshop on Hematology and Aging @ASH_hematology
5
186
Francesca Cottini retweeted
Pub Alert 🚨 @FrancescaCottin and other members from the #MultipleMyeloma Team published “Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma” in @FrontOncology
pubmed.ncbi.nlm.nih.gov/3755…
Francesca Cottini retweeted
How can you access personalized #Myeloma care and treatment? Hear advice from experts @Ashley_Rosko1 and @FrancescaCottin of @OSUCCC_James. buff.ly/3PrRMAY #MMsm
LLS Visionaries of the Year 2023 on @Bonfire bonfire.com/lls-visionaries-…
95
Francesca Cottini retweeted
Register for Patient Empowerment Network webinar: Accessing Personalized #Myeloma Treatment | What Patients Should Know on May 3 with @Ashley_Rosko1 and @FrancescaCottin of @OSUCCC_James. #MMsm:fal.cn/3xSm6


































